Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-24 @ 5:37 PM
NCT ID:
NCT00763568
Eligibility Criteria:
Inclusion Criteria:
* Chronic hepatitis C
Exclusion Criteria:
* Previously failed to respond to at least 12 weeks of peginterferon plus ribavirin combination therapy.
* Unable to take oral medication.
* Females who are either pregnant, breast-feeding or not using birth control.
* Males whose female partners are pregnant or plan to become pregnant.
* Other causes of liver disease (for example, autoimmune hepatitis, decompensated liver disease).
* Patients with HIV, HAV, HBV or HDV.
* Patients with a history of alcoholism or with an alcohol consumption of more than 40 grams per day.
* Patients with hemoglobinopathies (for example, thalassemia major, sickle-cell anemia).
* History of hypersensitivity or intolerance to nitazoxanide or peginterferon.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00763568
Study Brief:
Protocol Section:
NCT00763568